Aug 2026· Cell Reports· Vol 45, pp. 117856 - 117856· 0 citations· 74 references
Medicine
TL;DR
It is shown that mut p53 alters translation and promotes changes in miRNA processing and mitochondrial function, providing a mechanistic rationale for historically reported but poorly understood phenotypes.
Abstract
SUMMARY Tumor suppressor p53 is a transcription factor mutated in ~50% of cancers. Somatic mutations in the DNA-binding domain abolish tumor suppression and thus lead to a loss-of-function activity, while a small subset of recurrent “hotspot” mutants have been shown to confer gain-of-function activities. Using an intein-based μMap photoproximity labeling approach, we map the interactomes of five hotspot mutants and find that mutant p53 (mut p53) acquires interactions with RNA-binding proteins, shifts toward the cytoplasm, and shows increased proximity to structured RNA and RNA-binding proteins. CLIP (Cross-linking and immunoprecipitation) experiments show that mut p53 possesses an RNA-binding motif and is enriched at 3′UTRs, promoting ribosomal localization and localization at the mitochondrial surface. Using ribosome profiling, we further show that mut p53 alters translation and promotes changes in miRNA processing and mitochondrial function, providing a mechanistic rationale for historically reported but poorly understood phenotypes.
Findings demonstrate that PTBP1 supports AML proliferation by fine-tuning the expression and splicing of AML-essential genes, providing a workflow for systematically annotating RNA-associated protein dependencies in cancer.
Zhendong Cao, Kurtis N. McCannell, Si-Xiang Yu et al.· Leukemia· 0 citations
tRNA-derived fragments (tRFs) are a relatively recently discovered class of small RNAs implicated in gene-regulation, particularly behaving as microRNA to degrade target mRNAs with seed-sequence matches, but there have been very few reports of a clear phenotypic role of these small RNAs in cancer cell growth and other...
Fatemeh Esmaeili, Kumarjeet Banerjee, Ajay Chatrath et al.· Molecular Cancer Research· 0 citations
By integrating protein structures with mutation data from 139,818 patients, this study generates detailed, functional maps of mutations for 173 cancer genes in 18+ tumor types, providing a proteo-genomic framework to characterize the effects of mutations in tumorigenesis and integrate them into workflows for clinical i...
D. Hyeon, Yu-Xiang Zhou, Wendy K. Chung et al.· Cancer Cell· 1 citation
This review integrates the molecular logic of splice-site selection with the cancer-specific mechanisms that perturb it, summarizes representative isoform switches across the hallmarks of cancer, evaluates emerging technologies and clinical biomarkers, and discusses the opportunities and constraints of translating spli...
TP53 mutation may not only compromise its multifaceted tumor-suppressive functions but also confer oncogenic properties. Here, we demonstrate that DNA-binding domain mutations of TP53 unexpectedly confer a transcriptional regulatory function, directly driving RNA-splicing factor RBM28 overexpression. Overexpressed RBM2...
Tao Xiang, Zi-Yi He, Xiao Hu et al.· Nature Communications· 0 citations
The role of adaptive mRNA structures in regulating gene expression in mammalian cells remains poorly understood. Synonymous mutations have been linked to a range of diseases, including cancer, yet their impact on cell biology remains largely unexplored. This opinion focuses on how cancer-associated synonymous mutations...
Robin Fåhraeus· Trends in Cancer· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.